News: Molecular Biosciences
Read the latest news from the College of Natural Sciences at The University of Texas at Austin
Newly Discovered Antimicrobial Could Prevent or Treat Cholera
Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.
UT News
Newly Discovered Antibody Protects Against All COVID-19 Variants
Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.
Department of Molecular Biosciences
Forever Chemical Pollution Can Now Be Tracked
Professor of molecular biosciences David Hoffmann helped develop a new way to fingerprint a type of forever chemical.
AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria
Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.
The University of AI
Art Markman and K.P. Procko consider how artificial intelligence is already changing the college experience, its promise and pitfalls, and future directions.
Persistent Strain of Cholera Defends Itself Against Forces of Change, Scientists Find
Unique immune component has kept one strain of cholera on top for more than 60 years.
Faculty Members Elected to National Academy of Sciences
Neuroscientist Kristen Harris and molecular bioscientist Keiko Torii have received one of the highest honors a scientist can receive.
Two UT Scientists Elected to American Academy of Arts and Sciences
Chemist Eric Anslyn and molecular bioscientist Howard Ochman are among the UT faculty joining the Academy.
11 Faculty Members Elected Fellows of the American Association for the Advancement of Science
Jaquelin Dudley, Kristen Grauman, Arlen Johnson, Daniel Leahy, Xiaoqin “Elaine” Li and Tanya Paull receive major honor from AAAS.
Alzheimer’s Drug Fermented With Help From AI and Bacteria Moves Closer to Reality
An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.